Xavier I.
- Country
- France
- Department
- Pediatric Neurometabolism
Research Overview
- A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study with Open-Label Extension Period to Assess the Efficacy and Safety of Selexipag as Add-On Treatment to Standard of Care in Children Aged ≥2 to <18 years with Pulmonary Arterial Hypertension
- Evaluation of Flecainide for Reducing Atrial Arrhythmia Risk Post-Patent Foramen Ovale Closure in Patients
- Evaluation of Mavacamten on Left Ventricular Outflow Tract Obstruction in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy
Data & Insights
Has run more than one trial at 6 of 50 partner sites.
Specializations
Cardiac Rhythm Management
The investigator specializes in addressing atrial arrhythmias and their prevention, particularly in patients undergoing patent foramen ovale closure. Their research explores innovative therapeutic approaches to manage cardiac rhythm complications following interventional procedures.
- Post-procedural arrhythmia prevention
- Patent foramen ovale interventions
- Cardiac rhythm monitoring
Cardiomyopathy Treatment
Their work focuses on advanced treatments for obstructive hypertrophic cardiomyopathy, with particular attention to adolescent patients. The investigator studies interventions targeting left ventricular outflow tract obstruction in symptomatic cases.
- Pediatric cardiomyopathy management
- Ventricular function assessment
- Novel therapeutic approaches
Pediatric Pulmonary Hypertension
The investigator conducts research in treating pulmonary arterial hypertension in children, focusing on combination therapy approaches. Their work encompasses evaluating new therapeutic options for young patients aged 2 to 18 years with PAH.
- Pediatric PAH management
- Disease progression monitoring
- Combination therapy assessment
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.